A detailed history of Parallel Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 66,155 shares of EW stock, worth $4.33 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
66,155
Previous 63,399 4.35%
Holding current value
$4.33 Million
Previous $6.06 Million 0.86%
% of portfolio
0.16%
Previous 0.17%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$84.3 - $94.31 $232,330 - $259,918
2,756 Added 4.35%
66,155 $6.11 Million
Q1 2024

May 06, 2024

BUY
$72.54 - $95.56 $482,173 - $635,187
6,647 Added 11.71%
63,399 $6.06 Million
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $88,985 - $112,129
-1,442 Reduced 2.48%
56,752 $4.33 Million
Q3 2023

May 20, 2024

SELL
$69.28 - $93.38 $20,853 - $28,107
-301 Reduced 0.51%
58,194 $4.03 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $20,853 - $28,107
-301 Reduced 0.51%
58,194 $4.03 Million
Q2 2023

May 20, 2024

BUY
$81.41 - $94.33 $72,617 - $84,142
892 Added 1.55%
58,495 $5.52 Million
Q2 2023

Aug 04, 2023

BUY
$81.41 - $94.33 $72,617 - $84,142
892 Added 1.55%
58,495 $5.52 Million
Q1 2023

May 20, 2024

SELL
$74.26 - $84.51 $430,410 - $489,819
-5,796 Reduced 9.14%
57,603 $4.77 Million
Q1 2023

Apr 25, 2023

BUY
$74.26 - $84.51 $3.89 Million - $4.43 Million
52,443 Added 1016.34%
57,603 $4.77 Million
Q4 2022

Feb 03, 2023

SELL
$68.3 - $87.44 $89,609 - $114,721
-1,312 Reduced 20.27%
5,160 $384,000
Q3 2022

Nov 10, 2022

SELL
$82.37 - $107.29 $109,057 - $142,051
-1,324 Reduced 16.98%
6,472 $535,000
Q2 2022

Aug 01, 2022

BUY
$86.5 - $128.27 $27,074 - $40,148
313 Added 4.18%
7,796 $741,000
Q1 2022

Apr 28, 2022

SELL
$101.96 - $128.34 $73,921 - $93,046
-725 Reduced 8.83%
7,483 $876,000
Q4 2021

Jan 20, 2022

BUY
$106.37 - $130.68 $57,546 - $70,697
541 Added 7.06%
8,208 $1.06 Million
Q3 2021

Nov 02, 2021

BUY
$102.91 - $122.75 $335,074 - $399,674
3,256 Added 73.82%
7,667 $868,000
Q2 2021

Aug 06, 2021

BUY
$83.84 - $104.76 $73,276 - $91,560
874 Added 24.71%
4,411 $457,000
Q1 2021

Apr 23, 2021

BUY
$78.68 - $90.67 $21,558 - $24,843
274 Added 8.4%
3,537 $296,000
Q4 2020

Feb 02, 2021

SELL
$71.69 - $91.23 $45,379 - $57,748
-633 Reduced 16.25%
3,263 $298,000
Q3 2020

Oct 27, 2020

BUY
$67.19 - $87.44 $11,959 - $15,564
178 Added 4.79%
3,896 $311,000
Q2 2020

Jul 16, 2020

BUY
$57.54 - $76.95 $143,965 - $192,528
2,502 Added 205.76%
3,718 $256,000
Q1 2020

Apr 27, 2020

BUY
$52.41 - $81.0 $10,691 - $16,524
204 Added 20.16%
1,216 $229,000
Q4 2019

Jan 30, 2020

BUY
$71.7 - $82.09 $1,218 - $1,395
17 Added 1.71%
1,012 $236,000
Q3 2019

Nov 01, 2019

BUY
$61.55 - $75.43 $32,559 - $39,902
529 Added 113.52%
995 $219,000
Q2 2019

Aug 05, 2019

SELL
$55.74 - $64.41 $390 - $450
-7 Reduced 1.48%
466 $86,000
Q1 2019

May 01, 2019

SELL
$47.89 - $64.05 $10,104 - $13,514
-211 Reduced 30.85%
473 $90,000
Q4 2018

Feb 05, 2019

BUY
$46.41 - $56.94 $3,202 - $3,928
69 Added 11.22%
684 $101,000
Q3 2018

Nov 01, 2018

BUY
$45.7 - $58.03 $9,140 - $11,606
200 Added 48.19%
615 $99,000
Q2 2018

Jul 30, 2018

BUY
$42.45 - $51.3 $4,075 - $4,924
96 Added 30.09%
415 $60,000
Q1 2018

May 08, 2018

BUY
$37.19 - $47.45 $111 - $142
3 Added 0.95%
319 $45,000
Q4 2017

Feb 13, 2018

BUY
$33.79 - $39.39 $3,919 - $4,569
116 Added 58.0%
316 $36,000
Q3 2017

Nov 15, 2017

BUY
$36.29 - $38.83 $7,258 - $7,766
200 New
200 $21,000
Q3 2017

Nov 14, 2017

SELL
$36.29 - $38.83 $7,366 - $7,882
-203 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
203
203 $23,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.